Concepedia

Kavya Ramkumar

KR

16

Publications

1.7K

Citations

13

H-Index

2008

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Campania "Luigi Vanvitelli"

The University of Texas Southwestern Medical Center

AstraZeneca (United States)

Kavya Ramkumar is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2008–2025

16

Publications

16

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

, , +11

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Carminia Maria Della Corte, Triparna Sen, Carl M. Gay et al. · Journal of Thoracic Oncology · 2020 · 188 citations · Full text

, , +5

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic et al. · Journal of Thoracic Oncology · 2019 · 118 citations · Full text

, , +10

The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer

Soma Samanta, Suhui Yang, Bikash Debnath et al. · Cancer Research · 2021 · 111 citations · Full text

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

Kasey R. Cargill, C. Allison Stewart, Elizabeth M. Park et al. · Cancer & Metabolism · 2021 · 60 citations · Full text

Rows per page

1–5 of 16